Mortality and morbidity in cryptogenic (type C) compensated cirrhosis: a multicenter study
Giovanna Fattovich(University of Modena and Reggio Emilia), G. Realdi, F. Tremolada, Franco Noventa(University of Padua), Patrizia Fuschi(University of Verona), Anshul Bhalla, Paola Bonetti(Center for Pediatric Endocrinology Zurich), Antonio Solinas(University of Sassari), Jovan Basho(University of Verona), Corinne Njapoum(University of Verona), C. Casarin(University of Verona), G. Diodati, Rachel Galassini, A. Tocco(University of Verona), Piero Luigi Almasio, Frederik Nevens, H.C. Thomas, Françoise Degos(Inserm), Solko W. Schalm(Erasmus MC), J.T. Brouwer, D. Mura(University of Verona), G. Giustina(University of Verona)
Hepatology
January 1, 1995
Cited by 1
Related Papers
International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis
|Journal of Hepatology|1999|2.9k
Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis
|Blood|2002|1.9k
Morbidity and mortality in compensated cirrhosis type C: A retrospective follow-up study of 384 patients
|Gastroenterology|1997|1.4k
A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score
|Journal of Thrombosis and Haemostasis|2010|1.2k
A proposed system for the nomenclature of hepatitis C viral genotypes
|Hepatology|1994|1k